Literature DB >> 35111624

White matter damage in patients with mild cognitive impairment in Parkinson's disease.

Qian-Qian Li1, Ke Wu1, Jia-Li Xu2, Liang Yin1.   

Abstract

BACKGROUND: This study investigates the correlation between white matter structural damage and cognitive impairment in patients with Parkinson's disease (PD) and mild cognitive impairment (MCI).
METHODS: A total of 40 patients with PD were divided into two groups, i.e., a mild cognitive impairment (PD-MCI) and a normal cognitive (PDN) group, and 20 healthy patients were enrolled as the control group. Changes in the white matter structure of patients with PD were evaluated using diffusion tensor imaging (DTI), and cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA) scale and Mini-Mental State Examination (MMSE). Finally, the correlations between the two groups were analyzed.
RESULTS: The Unified Parkinson's Disease Rating Scale score was significantly higher in the PD-MCI than in the PDN group (P=0.008). The total MoCA and MMSE scores in the PD-MCI group were significantly lower than in the PDN and control groups (P<0.01). Patients in PDMCI group were tested by MMSE scale, and the abnormal score rate was 60.0%. Among them, 8 PD patients with normal MMSE total score were found to have mild cognitive impairment by MoCA evaluation. When compared with the PDN and control groups, the MoCA scores for visual space, which is assessed as part of the MoCA scale and generally represents bilateral parietal function; naming; memory; and attention were significantly lower in the PD-MCI group (P<0.001). When compared with the PDN group, the fractional anisotropy (FA) values for the right parietal and left occipital lobes were significantly lower in the PD-MCI group (P=0.005; P=0.018). The relationship between MoCA value and right parietal white matter and left occipital white matter was 0.555, 0.474, respectively. A Pearson's correlation test was conducted to compare the FA values and MoCA scores of the various brain areas in the PD-MCI group and revealed a significant positive correlation between the MoCA score and the white matter of the right parietal and left occipital lobes (P<0.01).
CONCLUSIONS: Patients with PD experience early cognitive impairment, and the MoCA scale can be used for early screening. In addition, the DTI of white matter can highlight early white matter damage. In the current study, the damaged brain areas displayed by DTI were consistent with areas showing decreased MoCA scores and were positively correlated with the severity of PD. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Montreal Cognitive Assessment scale; Parkinson’s disease (PD); diffusion tensor imaging; early cognitive impairment; white matter damage

Year:  2022        PMID: 35111624      PMCID: PMC8739131          DOI: 10.21037/qims-21-579

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  22 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai.

Authors:  Zhen-Xin Zhang; Gustavo C Roman; Zhen Hong; Cheng-Bing Wu; Qiu-Ming Qu; Jue-Bing Huang; Bing Zhou; Zhi-Ping Geng; Ji-Xing Wu; Hong-Bo Wen; Heng Zhao; Gwendolyn E P Zahner
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

3.  Diffusion tensor MR imaging in diffuse axonal injury.

Authors:  Konstantinos Arfanakis; Victor M Haughton; John D Carew; Baxter P Rogers; Robert J Dempsey; M Elizabeth Meyerand
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

4.  MR diffusion tensor spectroscopy and imaging.

Authors:  P J Basser; J Mattiello; D LeBihan
Journal:  Biophys J       Date:  1994-01       Impact factor: 4.033

5.  White matter microstructure changes in the thalamus in Parkinson disease with depression: A diffusion tensor MR imaging study.

Authors:  W Li; J Liu; F Skidmore; Y Liu; J Tian; K Li
Journal:  AJNR Am J Neuroradiol       Date:  2010-08-12       Impact factor: 3.825

Review 6.  Parkinson's disease: a short story of 200 years.

Authors:  L Cuenca; A L Gil-Martinez; L Cano-Fernandez; C Sanchez-Rodrigo; C Estrada; E Fernandez-Villalba; M T Herrero
Journal:  Histol Histopathol       Date:  2018-12-12       Impact factor: 2.303

Review 7.  Dementia and cognitive impairment: epidemiology, diagnosis, and treatment.

Authors:  Julie Hugo; Mary Ganguli
Journal:  Clin Geriatr Med       Date:  2014-06-12       Impact factor: 3.076

8.  Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.

Authors:  Roberta Biundo; Luca Weis; Silvia Facchini; Patrizia Formento-Dojot; Annamaria Vallelunga; Manuela Pilleri; Angelo Antonini
Journal:  Parkinsonism Relat Disord       Date:  2014-01-22       Impact factor: 4.891

Review 9.  Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.

Authors:  Klaus Seppi; K Ray Chaudhuri; Miguel Coelho; Susan H Fox; Regina Katzenschlager; Santiago Perez Lloret; Daniel Weintraub; Cristina Sampaio
Journal:  Mov Disord       Date:  2019-01-17       Impact factor: 10.338

10.  Aberrant cerebral perfusion pattern in amnestic mild cognitive impairment and Parkinson's disease with mild cognitive impairment: a comparative arterial spin labeling study.

Authors:  Song'an Shang; Jingtao Wu; Yu-Chen Chen; Hongri Chen; Hongying Zhang; Weiqiang Dou; Peng Wang; Xin Cao; Xindao Yin
Journal:  Quant Imaging Med Surg       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.